# Growth Hormone as a Model for Reversible Activation of Adipose Tissue Fibrosis

> **NCT04998500** · NA · UNKNOWN · sponsor: **University of Aarhus** · enrollment: 10 (estimated)

## Conditions studied

- Fibrosis

## Interventions

- **BIOLOGICAL:** Growth hormone, saline and GH receptor blockade (Pegvisomant)

## Key facts

- **NCT ID:** NCT04998500
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04998500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04998500, "Growth Hormone as a Model for Reversible Activation of Adipose Tissue Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04998500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*